← zu den Großinvestoren
Bain Capital Life Sciences Investors, LLC
Vermögensverwalter · Portfolio $1.68 Mrd. · 21 Positionen · Bericht zum 30.06.2026
Aktienpositionen Bericht für 30.06.2026, eingereicht am 14.08.2026; Veränderung – ggü. 31.03.2026 · 22
| Unternehmen | Aktien | Wert | % des Portfolios | Veränderung im Quartal |
|---|---|---|---|---|
| Kailera Therapeutics, Inc. US:KLRA | 22 583 268 | $498 Mio. | 29.58% | neu |
| Heartflow, Inc. US:HTFL | 8 448 158 | $248 Mio. | 14.74% | −2 000 000 |
| NEWAMSTERDAM PHARMA COMPANY CUSIP N62509109 | 3 806 566 | $129 Mio. | 7.67% | −3 500 000 |
| Savara Inc US:SVRA | 17 600 621 | $108 Mio. | 6.45% | — |
| ALKERMES PLC CUSIP G01767105 | 1 937 938 | $102 Mio. | 6.04% | +1 327 938 |
| Solid Biosciences LLC US:SLDB | 9 808 819 | $98.0 Mio. | 5.83% | — |
| PHARVARIS N V CUSIP N69605108 | 2 675 509 | $92.5 Mio. | 5.50% | — |
| Olema Pharmaceuticals Inc US:OLMA | 7 085 249 | $88.6 Mio. | 5.27% | −387 989 |
| Hemab Therapeutics Holdings,… US:COAG | 1 650 000 | $60.6 Mio. | 3.60% | neu |
| Cabaletta Bio Inc US:CABA | 17 241 445 | $53.6 Mio. | 3.19% | +7 564 320 |
| X4 Pharmaceuticals Inc US:XFOR | 7 967 454 | $37.2 Mio. | 2.21% | — |
| Dianthus Therapeutics Inc. US:DNTH | 362 470 | $35.3 Mio. | 2.10% | — |
| C4 Therapeutics, Inc. US:CCCC | 7 171 910 | $33.5 Mio. | 1.99% | — |
| Kyverna Therapeutics, Inc. US:KYTX | 2 885 000 | $25.7 Mio. | 1.53% | −225 000 |
| Annexon, Inc. US:ANNX | 4 437 731 | $25.3 Mio. | 1.51% | −774 943 |
| Rapid Micro Biosystems Inc US:RPID | 8 434 560 | $14.6 Mio. | 0.87% | — |
| Disc Medicine Inc. US:IRON | 141 234 | $10.3 Mio. | 0.61% | — |
| Atea Pharmaceuticals Inc US:AVIR | 2 075 639 | $9.65 Mio. | 0.57% | −284 999 |
| Xilio Development Inc US:XLO | 664 021 | $6.36 Mio. | 0.38% | — |
| Upstream Bio, Inc. US:UPB | 600 949 | $4.16 Mio. | 0.25% | −266 262 |
| NEWAMSTERDAM PHARMA COMPANY CUSIP N62509117 | 99 999 | $2.14 Mio. | 0.13% | — |
| CENTESSA PHARMACEUTICALS CUSIP 152309100 | 0 (war 635 000) | — | — | verkauft |
In Unternehmen Unserer Datenbank 13
| Unternehmen | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| Rapid Micro Biosystems Inc | 18.47% | 8 434 560 | 2026-06-30 |
| Kailera Therapeutics, Inc. | 17.42% | 22 583 268 | 2026-06-30 |
| Cabaletta Bio Inc | 10.17% | 17 241 445 | 2026-06-30 |
| Xilio Development Inc | 10.09% | 664 021 | 2026-06-30 |
| Heartflow, Inc. | 9.72% | 8 448 158 | 2026-06-30 |
| Solid Biosciences LLC | 8.79% | 9 808 819 | 2026-06-30 |
| Olema Pharmaceuticals Inc | 8.1% | 7 085 249 | 2026-06-30 |
| X4 Pharmaceuticals Inc | 8.04% | 7 967 454 | 2026-06-30 |
| Kyverna Therapeutics, Inc. | 4.67% | 2 885 000 | 2026-06-30 |
| Pharvaris N.V. | 4.09% | 2 675 509 | 2026-06-30 |
| Hemab Therapeutics Holdings,… | 3.53% | 1 650 000 | 2026-06-30 |
| NewAmsterdam Pharma Company… | 3.18% | 3 806 566 | 2026-06-30 |
| Atea Pharmaceuticals Inc | 2.59% | 2 075 639 | 2026-06-30 |
Anzeige